Today: 9 April 2026
Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

New York, Jan 28, 2026, 13:01 (EST) — Regular session

  • Applied Optoelectronics shares jumped roughly 18%, hitting $44.05 in midday trading
  • Oxford Instruments announced it will provide plasma etch and deposition systems to AOI’s facility in Sugar Land, Texas
  • Investors are focused on today’s Fed decision, looking for its impact on rate-sensitive tech stocks

Applied Optoelectronics Inc shares surged nearly 18% on Wednesday following Oxford Instruments’ announcement that it secured a plasma equipment supply deal linked to the U.S. optical components firm’s expansion in Texas. By 12:45 p.m. EST, the stock had climbed roughly 17.8% to $44.05, hitting a session high of $44.25. SEMI

This announcement hits differently because investors see anything connected to AI data-center expansions as a high-voltage trigger. For small-to-midcap suppliers, fresh capacity plans often send shares jolting more than any spreadsheet forecast could.

Oxford Instruments announced it will provide several etch and deposition “cluster” systems to Applied Optoelectronics’ facility in Sugar Land, Texas. The move supports AOI’s push to scale up indium phosphide production for optoelectronic devices. Fred Chang, an AOI executive, said the expansion targets “demand for our optical transceivers in AI data centers,” noting the new tools could boost quality and cut costs. Emiel Thijssen from Oxford Instruments called AOI “a valued long-term partner.” semiconductor-today.com

The rally pushed AAOI past several competitors today. Viavi Solutions climbed around 3.0%, Lumentum Holdings rose close to 2.9%, and Coherent eked out a 0.9% gain. Fabrinet, however, dipped about 1.4%.

A regulatory filing earlier this week revealed that AOI’s CFO, Stefan J. Murry, handed over 7,150 shares on Jan. 22 to cover tax withholding related to vested restricted stock units, opting not to sell them on the open market. The Form 4 was signed and submitted on Jan. 26. sec.gov

Etch and deposition are the chipmaking steps often described as “cut” and “coat”: etch removes material from the wafer, while deposition deposits ultra-thin layers. Indium phosphide, a compound semiconductor, finds use in lasers and high-speed optical components—a niche gaining traction as data centers race toward faster connections.

Applied Optoelectronics develops and markets fiber-optic networking gear, such as optical modules and lasers, for broadband and data-center applications. Seeking Alpha

The broader market lent support as well. Chip-related shares held steady Wednesday, with Wall Street gearing up for big tech earnings and the Federal Reserve’s policy decision. Reuters

But there’s the usual caveat. Equipment supply agreements don’t guarantee immediate revenue, and installation plus qualification can take time—especially when manufacturers adopt new wafer sizes or automation processes. A slowdown in AI-related spending would quickly challenge the bullish outlook.

Turning to macro, the Fed’s statement drops at 2 p.m. EST, with Chair Jerome Powell speaking at 2:30 p.m. This slot often rattles high-growth tech stocks, even when no rate change is anticipated. Federal Reserve

Stock Market Today

  • Anterix (ATEX) Gains as Bull of the Day with Positive Earnings Surprises and Upward Estimates
    April 9, 2026, 8:47 AM EDT. Anterix (ATEX), focused on private wireless networks for critical infrastructure, especially U.S. electric utilities, stands as Zacks Rank #2 (Buy). Despite low Value and Growth grades, it beat earnings estimates four consecutive times, with an average surprise of 36%. Its latest quarterly loss was 35 cents per share versus an expected 57 cents, marking a 38.6% positive surprise. Analysts have revised earnings estimates upward for fiscal 2026, from $3.06 to $3.30 over 90 days, and slightly improved fiscal 2027 loss forecasts. The company's focus on Private LTE technology and reliable communication infrastructure is attracting market attention amid shifting wireless needs.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout
Previous Story

Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week
Next Story

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Go toTop